Cargando…

Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease

BACKGROUND: Protection against infection by Newcastle disease virus (NDV), also designated as avian paramyxovirus subtype-1 (APMV-1), is mediated by immune responses to the two surface glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F) protein. Thus, a chimeric APMV-1 based vaccine that...

Descripción completa

Detalles Bibliográficos
Autores principales: Grund, Christian, Steglich, Constanze, Huthmann, Eva, Beer, Martin, Mettenleiter, Thomas C, Römer-Oberdörfer, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203933/
https://www.ncbi.nlm.nih.gov/pubmed/25297904
http://dx.doi.org/10.1186/1743-422X-11-179
_version_ 1782340466525601792
author Grund, Christian
Steglich, Constanze
Huthmann, Eva
Beer, Martin
Mettenleiter, Thomas C
Römer-Oberdörfer, Angela
author_facet Grund, Christian
Steglich, Constanze
Huthmann, Eva
Beer, Martin
Mettenleiter, Thomas C
Römer-Oberdörfer, Angela
author_sort Grund, Christian
collection PubMed
description BACKGROUND: Protection against infection by Newcastle disease virus (NDV), also designated as avian paramyxovirus subtype-1 (APMV-1), is mediated by immune responses to the two surface glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F) protein. Thus, a chimeric APMV-1 based vaccine that encodes APMV-8 HN- and F-proteins and expresses the hemagglutinin of avian influenza virus (AIV) H5N1, is able to protect against HPAIV H5N1 but fails to protect against NDV [PLoS One8:e72530, 2013]. However, it is unclear whether avirulent APMV-subtypes, like APMV-8 can induce subtype-specific immunity and protect from a homologous challenge. FINDINGS: APMV-8 infections of 3- and 6-weeks-old specific pathogen free (SPF)-chickens did not induce any clinical signs but was associated with virus shedding for up to 6 days. Viral replication was only detected in oropharyngeal- and never in cloacal swabs. Upon reinfection with homologous APMV-8, viral shedding was restricted to day 2 and in contrast to naive SPF-chickens, only RNA but no infectious virus was recovered. No protection was induced against virulent NDV challenge, although morbidity and mortality was delayed in APMV-8 primed chickens. This lack of protection is in line with a lack of reactivity of APMV-8 specific sera to APMV-1 HN-protein: Neither by hemagglutin-inhibition (HI) test nor immunoblot analyses, cross-reactivity was detected, despite reactivity to internal proteins. CONCLUSIONS: Immune responses mounted during asymptomatic APMV-8 infection limit secondary infection against homologues reinfection and facilitates a delay in the onset of disease in a subtype independent manner but is unable to protect against Newcastle disease, a heterologous APMV-subtype. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-422X-11-179) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4203933
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42039332014-10-22 Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease Grund, Christian Steglich, Constanze Huthmann, Eva Beer, Martin Mettenleiter, Thomas C Römer-Oberdörfer, Angela Virol J Short Report BACKGROUND: Protection against infection by Newcastle disease virus (NDV), also designated as avian paramyxovirus subtype-1 (APMV-1), is mediated by immune responses to the two surface glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F) protein. Thus, a chimeric APMV-1 based vaccine that encodes APMV-8 HN- and F-proteins and expresses the hemagglutinin of avian influenza virus (AIV) H5N1, is able to protect against HPAIV H5N1 but fails to protect against NDV [PLoS One8:e72530, 2013]. However, it is unclear whether avirulent APMV-subtypes, like APMV-8 can induce subtype-specific immunity and protect from a homologous challenge. FINDINGS: APMV-8 infections of 3- and 6-weeks-old specific pathogen free (SPF)-chickens did not induce any clinical signs but was associated with virus shedding for up to 6 days. Viral replication was only detected in oropharyngeal- and never in cloacal swabs. Upon reinfection with homologous APMV-8, viral shedding was restricted to day 2 and in contrast to naive SPF-chickens, only RNA but no infectious virus was recovered. No protection was induced against virulent NDV challenge, although morbidity and mortality was delayed in APMV-8 primed chickens. This lack of protection is in line with a lack of reactivity of APMV-8 specific sera to APMV-1 HN-protein: Neither by hemagglutin-inhibition (HI) test nor immunoblot analyses, cross-reactivity was detected, despite reactivity to internal proteins. CONCLUSIONS: Immune responses mounted during asymptomatic APMV-8 infection limit secondary infection against homologues reinfection and facilitates a delay in the onset of disease in a subtype independent manner but is unable to protect against Newcastle disease, a heterologous APMV-subtype. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-422X-11-179) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-08 /pmc/articles/PMC4203933/ /pubmed/25297904 http://dx.doi.org/10.1186/1743-422X-11-179 Text en © Grund et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Grund, Christian
Steglich, Constanze
Huthmann, Eva
Beer, Martin
Mettenleiter, Thomas C
Römer-Oberdörfer, Angela
Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title_full Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title_fullStr Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title_full_unstemmed Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title_short Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
title_sort avian paramyoxvirus-8 immunization reduces viral shedding after homologous apmv-8 challenge but fails to protect against newcastle disease
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203933/
https://www.ncbi.nlm.nih.gov/pubmed/25297904
http://dx.doi.org/10.1186/1743-422X-11-179
work_keys_str_mv AT grundchristian avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease
AT steglichconstanze avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease
AT huthmanneva avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease
AT beermartin avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease
AT mettenleiterthomasc avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease
AT romeroberdorferangela avianparamyoxvirus8immunizationreducesviralsheddingafterhomologousapmv8challengebutfailstoprotectagainstnewcastledisease